Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction

Henry Houlden1, Mathilde Girard, Charles Cockerell

  • 1Department of Molecular Neurosciences, Institute of Neurology, Queen Square, London, UK. h.houlden@ion.ucl.ac.uk

Annals of Neurology
|October 8, 2004
PubMed

Insights

A novel mutation in the Connexin 32 (Cx32) promoter impacts SOX10 binding, affecting peripheral nerve function in Charcot-Marie-Tooth disease patients.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Charcot-Marie-Tooth disease (CMT) is a group of inherited peripheral neuropathies.
  • Connexin 32 (Cx32) gene mutations are a common cause of X-linked CMT.
  • The Cx32 P2 promoter plays a crucial role in regulating Cx32 gene expression.

Purpose of the Study:

  • To investigate the impact of a novel Cx32 P2 promoter mutation on gene activity and protein binding.
  • To explore the role of SOX10 transcription factor in Cx32 gene regulation.
  • To elucidate the molecular mechanisms underlying peripheral nerve dysfunction in a CMT family.

Main Methods:

  • Genetic analysis to identify mutations in a CMT family.
  • Reporter gene assays to assess Cx32 promoter activity.
  • Electrophoretic mobility shift assays (EMSAs) to evaluate SOX10 binding affinity.

Main Results:

  • A novel mutation was identified in the Cx32 P2 promoter at -526bp within a conserved SOX10 binding site.
  • The mutation significantly reduced Cx32 promoter activity.
  • The mutation decreased the binding affinity of SOX10 to the Cx32 P2 promoter.

Conclusions:

  • The identified Cx32 P2 promoter mutation disrupts SOX10 binding and reduces gene expression.
  • This disruption contributes to peripheral nerve dysfunction in Charcot-Marie-Tooth disease.
  • The interaction between Cx32 promoter, SOX10, and EGR2 is a key mechanism in peripheral nerve health.